ReviewTheranostics2022

Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents.

Qingjuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.